Bank of America’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6
Closed -$165 6335
2025
Q4
$165 Sell
6
-24
-80% -$1.07K ﹤0.01% 6735
2025
Q3
$2.33K Buy
30
+28
+1,400% +$13.9K ﹤0.01% 7387
2025
Q2
$466 Buy
2
+1
+100% +$195 ﹤0.01% 7680
2025
Q1
$281 Hold
1
﹤0.01% 7623
2024
Q4
$257 Hold
1
﹤0.01% 7536
2024
Q3
$188 Buy
+1
New +$315 ﹤0.01% 7583
2024
Q2
Sell
-2
Closed -$661 7636
2024
Q1
$885 Sell
2
-50
-96% -$18.6K ﹤0.01% 7217
2023
Q4
$18.1K Buy
52
+50
+2,500% +$17.7K ﹤0.01% 6805
2023
Q3
$1.02K Sell
2
-162
-99% -$106K ﹤0.01% 7233
2023
Q2
$120K Buy
164
+57
+53% +$44.2K ﹤0.01% 6126
2023
Q1
$80.5K Sell
107
-159
-60% -$139K ﹤0.01% 6333
2022
Q4
$507K Buy
266
+264
+13,200% +$105K ﹤0.01% 5366
2022
Q3
$1K Hold
2
﹤0.01% 7675
2022
Q2
$1K Sell
2
-190
-99% -$298K ﹤0.01% 7870
2022
Q1
$662K Sell
192
-12
-6% -$31.4K ﹤0.01% 5613
2021
Q4
$618K Buy
204
+188
+1,175% +$872K ﹤0.01% 5682
2021
Q3
$104K Sell
16
-28
-64% -$242K ﹤0.01% 6703
2021
Q2
$577K Buy
44
+1
+2% +$15.7K ﹤0.01% 5306
2021
Q1
$719K Sell
43
-153
-78% -$2.99M ﹤0.01% 5093
2020
Q4
$3.33M Sell
196
-10
-5% -$188K ﹤0.01% 3505
2020
Q3
$3.87M Buy
206
+48
+30% +$1.1M ﹤0.01% 3143
2020
Q2
$4.16M Buy
158
+2
+1% +$56.7K ﹤0.01% 3000
2020
Q1
$3.42M Buy
156
+128
+457% +$2.05M ﹤0.01% 3038
2019
Q4
$262K Sell
28
-4
-13% -$38.6K ﹤0.01% 5454
2019
Q3
$302K Sell
32
-3
-9% -$36.5K ﹤0.01% 5409
2019
Q2
$561K Sell
35
-150
-81% -$2.48M ﹤0.01% 4980
2019
Q1
$3.81M Buy
185
+166
+874% +$2.95M ﹤0.01% 3418
2018
Q4
$236K Sell
19
-13
-41% -$225K ﹤0.01% 5416
2018
Q3
$781K Buy
32
+1
+3% +$30.5K ﹤0.01% 4645
2018
Q2
$1.05M Buy
31
+2
+7% +$76.7K ﹤0.01% 4436
2018
Q1
$1.15M Buy
29
+2
+7% +$75.9K ﹤0.01% 4296
2017
Q4
$1.23M Buy
27
+24
+800% +$1.12M ﹤0.01% 4346
2017
Q3
$144K Buy
+3
New +$165K ﹤0.01% 5528

Other funds holding KALA

Bank of America's KALA Position: Q1 2026 in Review

Bank of America sold out of KALA BIO (KALA) in Q1 2026, closing a stake of 6 shares — an estimated $165 sold.

Bank of America first reported a position in KALA in Q3 2017 and held it in 33 quarters. The position peaked at $4.16M in Q2 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • Bank of America reported no remaining KALA BIO position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 6 KALA BIO shares in Q1 2026, an estimated $165.
  • Bank of America first reported a position in KALA BIO in Q3 2017 and held it in 33 quarters.
  • Bank of America's KALA BIO position peaked at $4.16M in Q2 2020.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.